Back

Differences in patient characteristics and cardiovascular events between low dose and medium-high dose of Sacubitril-Valsartan

28 May 2018 (08:30 - 18:00)
Organised by:
Congress Presentation Part of: Poster Session 3 - Chronic Heart Failure – Treatment Pharmacotherapy HFA Premium Access Heart Failure 2018

About the speaker

Photo
Doctor Julia Seller Moya

Marina Health Hospital, Denia (Spain)

38 More presentations in this session

Presentation thumbnail
Miss M. Vester (Leiden, NL)
Abstract Slides
Presentation thumbnail
Associate Professor O. Havakuk (Tel Aviv, IL)
Abstract
Presentation thumbnail
Professor Z. RAISSUNI (Tanger, MA)
Abstract
Presentation thumbnail
Presentation thumbnail

Access the full session

Session thumbnail
Poster Session 3 - Chronic Heart Failure – Treatment

The Event

Event poster

Heart Failure 2018

28 May 2018 08:30 CET
You may be interested in
thumbnail
Congress Presentation
Left ventricular reverse remodeling following initiation of sacubitril/valsartan for heart failure with reduced ejection fraction and low blood pressure
27 August 2023
thumbnail
Congress Presentation
Association between dose of medications and mortality in heart failure with reduced ejection fraction: a systematic review and dose-response meta-analysis
20 May 2023
thumbnail
Congress Presentation
Sacubitril/valsartan improves exercise performance in patients with heart failure: a dose-dependent effect
24 June 2023
thumbnail
Congress Presentation
Treatment trajectory of Sacubitril/Valsartan initiation among >50,000 older adults with heart failure with reduced ejection fraction in the United States
21 May 2023

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources